ArticleAdvanced healthcare materials2026
The Distribution of Complement Proteins in Soft and Hard Coronas Impacts Macrophage Uptake of Nanoparticles.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Review
- Article
- MXene-Protein Corona Interfaces for Molecular Profiling of Alzheimer's Disease.bioRxiv : the preprint server for biology · 2026Article
- The Distribution of Complement Proteins in Soft and Hard Coronas Impacts Macrophage Uptake of Nanoparticles.Advanced healthcare materials · 2026Article
- Liposomal Nanoparticulate Drug Delivery Systems: Strategies to Destabilize Biological Membranes at the Target Tissue.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Complement proteins, as key constituents of the protein corona, facilitate the elimination of exogenous nanoparticles by immune cells, thereby limiting their tumor accumulation and therapeutic efficacy. Current research on complement proteins primarily focuses on the hard corona (HC), whereas their distribution and biological relevance in the soft corona (SC)-the dynamic layer directly interfacing with biological systems-remain underexplored. In this study, analyses in pooled and individual sera across different nanoparticle types, including carboxylated polystyrene nanoparticles (PS-COOH), silica magnetic nanoparticles (SMNs), and liposomes (Lips), revealed that the third complement protein (C3) fragments associated with both HC and SC, with their distribution dictated by nanoparticle surface chemistry. For PS-COOH and SMNs, iC3b is preferentially enriched in the SC, whereas Lips surface favored iC3b deposition within the HC, likely due to exposed amino groups that facilitate C3 attachment via thioester-amine reactions. Functional assays demonstrate that macrophage uptake is primarily driven by HC-bound iC3b, while SC proteins attenuate this process by shielding HC-bound C3 fragments and limiting their accessibility to complement receptors. Moreover, SC does not effectively mediate nanoparticle-phagocyte interactions, as its dynamic nature prevents stable engagement with cellular receptors. Collectively, these findings provide new mechanistic insights into SC-mediated clearance of nanomedicines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.